Combining monoclonal antibodies that target different parts of the virus can prevent escape mutations in SARS-CoV-2, offering a more durable and effective treatment strategy against evolving variants.
Most Recent Articles
Obicetrapib-Ezetimibe Combination Reduces LDL Cholesterol by Nearly 50% in Resistant Hypertension
A fixed-dose combination of obicetrapib and ezetimibe lowered LDL cholesterol by nearly 50% in high-risk patients on statins, offering a promising option for those with resistant hypercholesterolemia.
One in Seven U.S. Adults Aged 30-59 Have High 30-Year Risk for Cardiovascular Disease
Although most U.S. adults aged 30–59 have low 10-year cardiovascular risk, about 1 in 7 face high 30-year risk—highlighting the need for long-term assessments in preventive care.
Flavan-3-Ols: A Potential Dietary Intervention for Lowering Blood Pressure and Improving Endothelial Function
A meta-analysis of 145 trials found that flavan-3-ol-rich foods like cocoa and tea significantly lower blood pressure and improve endothelial function, especially in people with elevated baseline BP.
Amiloride Noninferior to Spironolactone for Reducing Systolic Blood Pressure in Resistant Hypertension
Amiloride was found to be non-inferior to spironolactone for lowering blood pressure in resistant hypertension, offering a well-tolerated alternative without hormonal side effects like gynecomastia.